FDA issued a warning letter to CanaRx for illegally distributing drugs into the U.S. that have not been approved by the FDA for safety and effectiveness.
FDA warns CanaRx for selling unapproved, misbranded and unsafe imported drugs to unsuspecting Americans
More from FDA News AlertsMore posts in FDA News Alerts »
- FDA Allows for First Point-of-Care Chlamydia and Gonorrhea Test to be Used in More Near-Patient Care Settings
- Coronavirus (COVID-19) Update: March 30, 2021
- Bit & Bet LLC Issues Voluntary Nationwide Recall of Thumbs Up 7 Blue 69K Due to Presence of Undeclared Sildenafil and Tadalafil
- Mammography Problems at Tennessee Women’s Care P.C. in Nashville, TN: FDA Safety Communication